Form 4 for YCBD cbdMD, Inc.
Accepted 2024-08-30 00:00:00 ET · period of report 2024-08-23 · accession 0001437749-24-028129 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-30 | 2024-08-23 | YCBD | Raines William F III | Dir | A - Grant | $0.00 | +75.0K | 84.3K | +810% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-23 | A | A | 75,000 | $0.00 | 84,256 | D | — | — | (F1) Pursuant to the Settlement, Purchase and Release Agreement dated August 23, 2024, entered into between the Issuer, CBD Industries, LLC and Majik Medicine, LLC ("Majik"), the Reporting Person was appointed as the true and lawful attorney, agent and proxy, with full power of substitution, for Majik for the issuance of 75,000 shares for 12 months from the Transaction Date (the "Proxy Period"). During the Proxy Period, the Reporting Person is entitled to (i) vote the shares at all shareholder meetings of the Issuer, (ii) execute instruments, consents, directions or other documents relative to the corporate affairs of the Issuer, (iii) calling for the approval or disapproval of any corporate act or transaction by the shareholders of the Issuer, and (iv) vote or otherwise act, upon any and all matters and questions relating to the Issuer. The Reporting Person shall vote in accordance with the recommendation of a majority of the independent members of the Issuer's Board of Directors. |